PREVIOUS PAPERS


Roujansky A. et al.
Analysis of Paradoxical Efficacy of Carbapenems against carbapenemase-producing Escherichia coli in a Murine Model of Lethal Peritonitis.
Antimicrob. Agents Chemother. 2020 May 18

de Lastours V. et al.
Mortality in Escherichia Coli Bloodstream Infections: Antibiotic Resistance Still Does Not Make It.
J. Antimicrob. Chemother. 2020 May 17

Jacquier H. et al.
Molecular Epidemiology of Neisseria gonorrhoeae Clinical Isolates in Reunion and Mayotte.
Sex. Transm. Infect. 2020 May 4

Deslandes A. et al.
SARS-CoV-2 Was Already Spreading in France in Late December 2019.
Int. J. Antimicrob. Agents 2020 May 3

Delory T. et al.
A Computerized Decision Support System (CDSS) for Antibiotic Prescription in Primary care-Antibioclic: Implementation, Adoption and Sustainable Use in the Era of Extended Antimicrobial Resistance.
J. Antimicrob. Chemother. 2020 May 1

Visseaux B. et al.
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection.
J. Clin. Microbiol. 2020 Apr 27

Andremont O. et al.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Med. 2020 Apr 20

Jouvin-Marche E. et al.
French research strategy to tackle antimicrobial resistance.
Lancet 2020 Apr 18

Caméléna F. et al.
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
J. Antimicrob. Chemother. 2020 Apr 16

Sallard E. et al.
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 7

Lescure FX. et al.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
Lancet Infect. Dis. 2020 Mar 27

Madelain V. et al.
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials.
CPT Pharmacometrics Syst. Pharmacol. 2020 Mar 20

Choudhury A. et al.
CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.
Mol. Syst. Biol. 2020 Mar 16

Marcelin AG. et al.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J. Antimicrob. Chemother 2020 Mar 10

Cointe A. et al.
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options
J. Antimicrob. Chemother. 2020 Mar 1

Charpentier C. et al.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)
J. Antimicrob. Chemother. 2020 Feb 24

Riglet F. et al.
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM. AAPS J. 2020 Feb 19

Peiffer-Smadja N. et al.
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
Clin. Microbiol. Infect. 2020 Feb 12

Hobson CA et al.
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam
Sci. Rep. 2020 Jan 17

Tubiana S. et al.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort
Clin. Microbiol. Infect. 2020 Jan 9

Le Hingrat Q. et al.
Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity
J. Virol. 2020 Jan 8